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Transposable elements have been used in Drosophila to detect
gene expression, inactivate gene function, and induce ectopic
expression or overexpression. We have combined all of these
features in a single construct. A promoterless GAL4 cDNA is
expressed when the construct inserts within a transcriptional unit,
and GAL4 activates a GFP-encoding gene present in the same
transposon. In a primary screen, patterned gene expression is
detected as GFP fluorescence in the live progeny of dysgenic males.
Many animals expressing GFP in distinct patterns can be recovered
with relatively little effort. As expected, many insertions cause loss
of function. After insertion at a genomic location, specific parts of
the transposon can be excised by FLP recombinase, thus allowing
it to induce conditional misexpression of the tagged gene. There-
fore, both gain- and loss-of-function studies can be carried out with
a single insertion in a gene identified by virtue of its expression
pattern. Using this promoter trap approach, we have identified a
group of cells that innervate the calyx of the mushroom body and
could thus define a previously unrecognized memory circuit.
gene function  GFP  memory  gene trap  misexpression
Determining the function of most genes is a long-term goal inthe postgenomic era. This enterprise was initiated many
decades ago, much before DNA sequencing, with the numerous
forward genetic screens that have been carried out in Drosophila
(1) and in other model organisms (2). Such screens have attained
an exquisite degree of sophistication, allowing very specific
biological functions to be probed. However, forward genetic
screens are unlikely to uncover the function of all genes because
their activity could be masked by redundancy. Moreover, the
function of many genes might be overlooked if they serve a subtle
function not needed for viability but essential for fitness in the
wild. This is likely to be the case for many brain functions.
Homologous recombination technology has the potential to
knock out every gene, although this technology is still very
laborious (3). Transgenic RNAi is another reverse genetic
approach that has a place in the postgenomic era (4), but it is
limited by the fact that it usually causes incomplete knock down
and that it is still relatively laborious because it requires the
construction and validation of individual transgenic strains. As
a complement to the loss-of-function assays, misexpression
screens based on the GAL4 system (5) have also been very
successful in uncovering the activity of many genes in specific
tissues (6). Ideally, however, gain-of-function analysis should
always be complemented by the loss-of-function phenotype.
The pattern of expression can be an alternative starting point
for a genetic screen. For example, our work on embryonic
boundaries in Drosophila suggests that segmentally expressed
genes involved in segmental groove formation remain to be
discovered (7). Presumably, these genes have not been identified
in the past because of redundancy. A screen based on expression
patterns could identify these genes as long as subsequent analysis
can probe the functional significance of such expression. Such an
approach could also be particularly suited to identify genes
involved in brain functions andor to uncover previously unrec-
ognized cell types in the brain. Expression-based screens have
previously been performed in Drosophila using LacZ-based
enhancer trap vectors (8–10). By current standards, the useful-
ness of enhancer trap insertions is limited by the effort needed
for subsequent functional and molecular characterization. The
advent of GFP technology provides an opportunity for dramat-
ically improving the efficiency and focus of expression-based
screens. Moreover, additional technological developments allow
functional assays to dovetail readily on an expression-based
screen. We report here on the design and activity of a transposon
that achieves these aims. Using this approach, we identify a
previously unrecognized group of cells that innervate the calyx
of mushroom bodies.
Results and Discussion
Design and Features of the Promoter Trap. A transposon carrying a
promoterless cDNA accurately reflects endogenous gene ex-
pression when integrated downstream of a genomic transcription
start site (11). However, f lies carrying this construct have to be
crossed to a GFP expressing reporter line to reveal the expres-
sion pattern in live animals. To allow the screening of new
patterns in the first generation, we included UAS-GFP within an
analogous GAL4-based construct (Fig. 1). Because the original
construct by Lukacsovich et al. (11) was shown to trap promoters,
the sequences upstream of GAL4 were kept the same, including
a splice acceptor site (SA) and a so-called stop-start site (one
small variation was added; see below). Because GFP and GAL4
are both present in our construct, the activity of endogenous
promoters should be detectable in the first generation progeny
of dysgenic animals. Moreover, because insertion of the trans-
poson introduces three transcription termination sites (one
downstream of GAL4, one in white, and one following GFP), it
is expected that transcription of the endogenous gene would be
prematurely terminated, thus leading to loss of function. To
enable gain-of-function experiments, we introduced sequences
that allow easy conversion to an inducible misexpression con-
struct (after insertion at a specific genomic location). Conversion
was achieved by introducing FLP recombination target (FRT)
variants at suitable positions such that both GAL4 and GFP
could be excised. A pair of mutated FRTs (called FRT2 here),
which are incompatible with the wild-type FRT but pair with
each other in vitro (12), were introduced on both sides of the
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coding sequence. Another pair of FRTs (FRT1), also incom-
patible with the wild-type FRT as well as with FRT2, was placed
on both sides of the GFP coding sequence (including the
polyadenylation site). In theory, FLP expression should excise
both GAL4 and GFP while leaving in place the intervening
sequence, which includes a miniwhite gene (as a marker) and the
UAS-promoter cassette. The latter, which drives GFP expression
before excision, should now point downstream into nearby
genomic sequences. Excision should allow expression of the
downstream gene in the presence of exogenous GAL4 (which
would be brought in by a genetic cross). Overall, we expect the
transposon to reveal active promoters by triggering transcription
and hence GFP expression. By design, therefore, only insertions
downstream of active endogenous promoters will be detected,
and sequencing of flanking sequences after inverse PCR should
unambiguously identify the tagged gene. In the cases in which the
transposon inserts upstream of the translation start, it should be
readily convertible into a misexpression construct after induc-
tion of GAL4 expression.
Testing the Conversion from Promoter Trap to Misexpression Con-
struct. Because the specificity of the mutated FRT pairs present
in our construct had not been tested previously in a heterologous
system, we assessed the effect of expressing FLP in three lines
picked from a small pilot screen. These represented insertions in
Mhc (Myosin heavy chain), elav, and CG6301. Recombination
was assessed by PCR in the progeny of males carrying both the
transposon and a FLP-encoding transgene expressed from a
testis-specific promoter (13). Primers were designed to amplify
either the GAL4- or GFP-encoding sequences along with nearby
flanking sequences (Fig. 2A). PCR amplification of the GAL4
region generated an expected band of 3.5 kb in the parental f lies,
whereas a 200-bp fragment was amplified with the same primers
after FLP expression. Likewise, a region encoding GFP was
amplified as a 2.7-kb fragment in the parental f lies, and this
fragment was reduced to 1 kb after crossing to the FLP-encoding
transgene. All three lines retained the red eye color, indicating
that the white gene, which is positioned betweenGAL4 andGFP
in the parental stock, was not excised by FLP (Fig. 2B). This
finding demonstrates that no cross-reactivity occurs between the
two pairs of FRTs. Because white is not excised, the UAS
promoter cassette is also expected to be retained after excision
of GAL4 and GFP. This, according to our expectation, should
allow expression of the downstream gene if the transposon is
inserted upstream of the endogenous start of translation. We
tested this directly for one of our line, which is inserted in the elav
gene. This line was chosen because anti-Elav antibodies are
readily available. Elav is normally expressed in the nervous
system (shown at stage 14 in Fig. 2D). GAL4 and GFP were
excised by crossing to flies expressing FLP as described above.
The resulting flies, which we refer to as ‘‘f lipped-out,’’ were
crossed to engrailed-GAL4 and embryos were stained with
anti-Elav. As can be seen, Elav is expressed in segmentally
repeated stripe, mirroring the domain of engrailed-GAL4 activity
(Fig. 2F). This finding demonstrates that the transposon can
indeed be converted to a misexpression construct upon exposure
to FLP.
A Pilot Screen. To assess the activity and efficiency of our
promoter trap, we mobilized it and screened for GFP expression
in embryos and larvae. A silent insertion (no GFP expression)
located on the third chromosome was used as a transposon
source. To achieve good gamete representation, one dysgenic
male was mated to 10 wild-type females. Depending on capacity,
embryos from 3,000 females were screened each day, and a
new GFP expression pattern is seen in 1 male out of 10. Thus,
30 new expression patterns per 3,000 females were identified.
Approximately 100 lines were established from single fluores-
cent animals isolated during a pilot screen. Various expression
patterns were selected (examples are shown in Fig. 3). In some
Fig. 1. Schematic representation of the promoter trap after it has inserted into an individual gene. Flanking genomic regions are shown in red with an arrow
marking the endogenous start of transcription. The ends of the P element are indicated by black triangles. After insertion of the transposon, the endogenous
promoter (UAS, upstream activating sequence) triggers transcription of and the subsequent production of GFP. A splice acceptor site (SA; AATTCTTATCCTT-
TCCTTTAGGCTAACGCCGAGGCCCAGAA) and a stopstart (TGATTGAATAAACATG) precede GAL4 as in the construct of Lukacsovich et al. (11). Both GAL4 and
GFP are individually flanked by modified 35-bp FRTs (FRT2 and FRT1, respectively). The central core sequence (shown in the figure for FRT2 and FRT1), which
determines specificity, was modified from the wild type (TCTAGAAA) to prevent cross-reactivity while still allowing self-pairing. After FLP expression, bothGAL4
and GFP are expected to be excised, leaving all other sequences intact, including the miniwhite gene.
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lines, GFP expression was restricted, e.g., to the ring gland as in
line 71. Other lines have a broad expression profile such as in line
50, which expresses GFP in many tissues such as the gut, trachea,
and epidermis. Although the screen was carried out with em-
bryos and early larvae, many insertions produce fluorescence
throughout the life of the fly. GFP expression was recorded and
is summarily described in Table 2, which is published as sup-
porting information on the PNAS web site. Of particular signif-
icance are the patterns of expression detected in the brain (see
below).
More than one-half of the insertions were located on the third
chromosome (Table 1), perhaps a consequence of the fact that
our jumpstarter transposon was on the third chromosome and
that local jumping is usually favored (14, 15). After our pilot
screen, two silent insertions have been introduced on a marked
second chromosome. Such a strain could be used as an alterna-
tive jumpstarter line that might favor insertions on the second
chromosome. Twenty-five percent of our insertions were ho-
mozygous lethal (Table 1), indicating that integration of the P
element can disrupt gene function as expected (16). However
nonlethal insertions in essential genes were found (e.g., elav),
maybe because a cryptic transcription start located downstream
of the insertion site could become active. For these insertions, a
loss-of-function mutation could be obtained by imprecise exci-
sion of the transposon. For 20 lines, the exact insertion site was
determined by inverse PCR (Fig. 5 and Table 3, which are
published as supporting information on the PNAS web site). Of
these 20 gene traps, 11 were in an exon and 9 were in an intron.
All but one were inserted before the start codon. For those,
Flp-mediated conversion would allow inducible expression of the
corresponding gene. Visual inspection showed that the embry-
onic expression of GFP driven by the promoter traps in cpo,
vha68, m(2)21ab, mesk2, lobe, and odd-skipped fits with the
corresponding in situ expression pattern posted on the Berkeley
Drosophila Genome Project web site (http:www.fruitf ly.org
cgi-binexinsitu.pl). For two promoter traps, congruence be-
tween expression of GFP and that of the endogenous gene was
verified by double immunofluorescence (line 106 in odd-skipped
[data not shown] and line 95 in elav [Fig. 2 D and E]). Note that
at any given stage, the GFP and in situ patterns were not always
identical. However, the differences could be attributed to a delay
in the appearance of GFP and to the perdurance of the GFP
signal after the endogenous gene has turned off. This effect is
illustrated for the odd gene in Fig. 6, which is published as
supporting information on the PNAS web site. Overall, it
appears that the promoter trap provides a good reporter of
endogenous gene activity. The promoter trap vector was found
to insert equally into introns and exons (Table 1). Interestingly,
for 19 of the 20 lines, the promoter trap inserted upstream of the
ATG (within the 5 UTR). In all of these cases, conversion to a
misexpression insertion should therefore be possible. Further-
more, some of these lines are homozygous lethal, indicating that
insertion of the promoter trap into the 5 UTR can cause
disruption to gene expression. Because there is no obvious
benefit from the splice acceptor site, an analogous construct was
made without the splice acceptor. It is likely that this could lead
to a higher proportion of GFP-expressing animals because out of
21 independent transformants, 6 expressed GFP in specific
patterns (no GFP-producing lines were obtained from the
original transformants carrying the original promoter trap). A
large-scale mobilization experiment will be needed to confirm
that efficiency is increased in the absence of a splice acceptor.
Fig. 2. Postinsertion conversion to a misexpression construct. (A) Genomic DNA was isolated from various lines, and DNA fragments were amplified by PCR with
primers indicated by red arrows in the diagram. Three insertions (inmhc,elav, andCG6301) were analyzed this way. (B) Fragments obtained by PCR. After excision
(see lanes marked FO for flipped-out; two independent excisions), a 200-bp fragment was detected with the GAL4-specific primers, whereas a 3.5-kb fragment
was produced in the parental flies. C, control; MHC, myosin heavy chain. Likewise, the flipped-out flies (three independent excisions) gave a 1-kb fragment with
theGFP-specific primers, whereas a 2.7-kb fragment was obtained from the parental flies. (C) Diagram of the insertion site of the promoter trap (yellow triangle)
in the 5 end of the elav gene (transcription is from right to left). (D) GFP expression in the parental stock (promoter trap in elav). GFP is detected in the CNS as
expected from a reporter of elav expression. (E) Immunocytochemical detection of Elav after FLP-mediated excision of GAL4 and GFP (PelavFO). (F) Elav expression
in an embryo from a cross between engrailed-GAL4 and PelavFO. Note the expression in stripes in addition to the normal CNS expression.














Identification of a Novel Group of Cells Innervating the Calyx. As
shown above, GFP expression from the promoter trap faithfully
reports on the normal endogenous pattern. We expected faith-
fulness to exceed that of enhancer traps because, with the
promoter trap, GAL4 is driven from a fusion transcript. GFP
expression was also expected to be strong, thanks to the GAL4-
mediated amplification step. The strength of the signal turned
out to be particularly useful in cases in which expression is
confined to a small number of cells. Strong expression can be
seen, for example, in larvae carrying the promoter trap in
odd-skipped, which is only expressed in 5–6 neurons in each
brain lobe at the third instar (Fig. 4E). The ease of visualizing
these groups of cells led us to postulate that genes expressed in
restricted patterns in the larval brain could be screened for at the
outset. The feasibility of this approach was tested by small-scale
mobilization of the promoter trap and screening for GFP
expression in the brain of larval progeny. Some examples are
shown in Fig. 4 A–E. In these lines, neuronal processes can later
be visualized by crossing the lines to flies carrying UAS-CD8-
GFP. Fig. 4A shows the pattern from a promoter trap in vha16,
a gene encoding a proton-transporting ATPase (http:f lybase.
bio.indiana.edu). As can be seen, the trap is expressed within the
brain lobes in a restricted number of cells that project predom-
inantly into the nerve cord. Another line (line 42) was found to
be expressed exclusively in surface glia (Fig. 4B). To our
knowledge, no such expression pattern has been reported pre-
viously. Fig. 4C shows the expression pattern from line 2 (B4),
which is expressed almost exclusively in a group of cells located
in an anterior-medial region of the brain lobe. Broader expres-
sion patterns were also identified in Fig. 4D.
The insertion into the odd-skipped gene is expressed at the
second instar in a cluster of 5–6 neurons in each brain lobe. With
CD8-GFP, these cells are seen to project into the calyx of the
mushroom body (white arrow in Fig. 4E) (for 3D visualization,
seeMovie 1, which is published as supporting information on the
PNAS web site). This finding is significant because all of the cells
known so far to innervate the calyx are Kenyon cells, yet the
odd-skipped cells (white arrow in Fig. 4F) are clearly distinct form
the Kenyon cluster: As can be seen in Fig. 4F, odd-skipped-
expressing cells (white arrow) do not colocalize with the Dachs-
hund-positive Kenyon cell (light blue arrow). Therefore, the
odd-skipped cells may define a previously unrecognized memory
circuit. Not only was the promoter trap instrumental in identi-
fying these cells, it also provides tools for future characterization.
For example, the ontogeny of these cells could be uncovered by
Fig. 3. Some examples of GFP patterns. The number at the bottom of each
panel refers to individual insertion lines. B,D, andG show photographs of live
embryos, and the remaining panels depict live larvae. (A) Line 34 shows
expression in the CNS and peripheral nervous system at larval stages. (B)
Embryonic expression in segmentally arranged clusters of cells of the epider-
mis. (C) Line 50 shows expression in the tracheal system, intestinal tract, and
the epidermis. (D) Line 4 is expressed in the CNS and the oenocytes. (E) Line 56
shows expression in the tracheal system. (F) Line 86 shows GFP expression in
the fat bodies and somatic musculature. (G) In embryos from line 98, GFP is
seen in narrow stripes of segmentally repeated epidermal cells. There is also
expression in scattered cells throughout the embryo. (H) Line 35 exhibits
exclusive expression in the ring gland. (I) Line 90 has GFP expression in
segmentally repeated cells of the embryonic epidermis.





lethal insertion3rd 2nd X
n  110 62 27 21 27
A majority of insertions were found on the 3rd chromosome. Twenty-seven
percent were homozygous lethal.
Fig. 4. Genes expressed in the brain. All images are of second instar larval
brains with GFP in green. Anterior is left and medial is up. Each image is of one
brain lobe. GFP is produced from the promoter trap itself as well as from a
UAS-CD8-GFP transgene to highlight cell processes. In A–E, the preparations
were stained with anti-N-cadherin (red) to visualize most neuronal processes.
The site of insertion was determined for the lines shown in A, C, and E (hence
the gene name is indicated above the corresponding panel). E shows the
odd-skipped-expressing neurons (green) and their projection into the calyx of
the mushroom body (white arrow) (for more details, see Movie 1). In F, the
odd-skipped-expressing neurons (white arrow) are shown in a preparation
stained with anti-Dachshund (red). The light blue arrow points to the Kenyon
cells.
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tracking them in live and fixed preparations. Our preliminary
analysis suggests that these cells originate from a posterior
cluster within the embryonic brain. In addition, GAL4 produced
by the promoter trap could be used to drive the expression of
additional markers such as CD2-HRP (7) to facilitate connec-
tivity studies at the EM level. A toxin could also be expressed for
cell ablation (17). Ablation could be done at a defined time if
GAL80 [ts] is introduced to allow the control of GAL4 activity
with temperature (18).
Conclusion
Our construct allows the efficient identification of genes that are
expressed in specific patterns within a tissue. Morin et al. (19)
reported a promoter trap vector that generates fusion proteins
between endogenous gene products and GFP. GFP fusions can
report on the subcellular localization of the endogenous product.
Seeing the subcellular localization is a distinct advantage, but it
comes at the cost of the need for three constructs (one for each
frame). Because of its simplicity, our promoter trap allows
numerous insertions (patterns) to be screened by a single human
operator in a relatively short time, and this can be further
increased by the use of a larvaembryo sorter. Efficiency and the
ability to screen in the first generation after dysgenesis is such
that one can afford to select only the desired patterns of
expression for further analysis. Another benefit of our promoter
trap is that, as a result of GAL4-mediated amplification, theGFP
signal is readily detectable even if expression is restricted to a
small number of cells. A further advantage of our construct is
that it easily lends itself to gain- and loss-of-function analysis.
Both gene and promoter traps allow the identification of the
disrupted gene because the insertions occur within the tran-
scription unit. All in all, the gene and promoter traps have
distinct benefits (chiefly the creation of GFP fusions for the
promoter trap and the bright signal and simplicity for the
promoter trap) and hence should complement each other.
As we have shown, our promoter trap can be used to identify
genes expressed in a particular tissue at any developmental stage
of interest even if the cell population is very small. A proof-of-
concept is provided by genes expressed in a subset of cells within
the brain. Systematic screening for such expression patterns
could provide a palette of tools to probe the development and
function of various parts of the brain. Mutations in head gap
genes such as orthodenticle, empty spiracles, tailless, and button-
head (20, 21) have been known to cause large-scale deletions in
the brain. However, relatively few mutations are known to affect
restricted neuronal circuits in either embryos or larvae. The
features of our promoter trap should help characterizing such
circuits. As an assessment of this paradigm, it would be useful to
test the role of the odd-skipped cluster and probing the role of
odd-skipped in the development and function of mushroom
bodies.
Materials and Methods
Construct of the Transposon. Standard techniques of molecular
biology were used. The full sequence of the transposon is
available upon request.
Fly Stocks and Mating Crosses. The jumpstarter stock used for our
pilot screen carried a silent insertion on the third chromosomes.
Mobilization was carried out by crossing flies containing the P
element to flies carrying 2–3 as a source of transposase (20).
Male progeny from this cross were mated to females from a
white virginizer stock containing heat shock-hid on the Y
chromosome (a gift from Ruth Lehman, Skirball Institute, New
York, NY). Progeny was screened by using a standard dissecting
microscope with a fluorescence source or a COPAS embryo
sorter (Union Biometrica, Holliston, Massachusetts). The fol-
lowing fly stocks were used for further experiments: engrailed-
GAL4 (a gift from Andrea Brand, Cambridge University, Cam-
bridge, U.K.) and a strain carrying FLP under the control of a
testis-specific tubulin promoter (13).
Primers to Test FLP-Mediated Recombination. The region was am-
plified with CGGACATTGACGCTAGGTAAC and GGATT-
TGCCATTGATCCTTCG, whereas GFP was amplified with
CCGTTCGGAGTGATTAGGT and CACGTGCCGAAGT-
GTGCTATT.
Inverse PCR. Inverse PCR was performed following the Berkeley
Drosophila Genome Project standard protocol (as described in
FlyBase) except that alternative primers were used in most cases:
GGAGGCGACTCAACGCAGATG and CACCCAAGGC-
TCTGCCCCACAAT. In some cases, reliable PCR fragments
were generated with the primers suggested by the Berkeley
Drosophila Genome Project.
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